DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 119 filers reported holding DENALI THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,041,815 | -30.1% | 50,500 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $1,490,255 | +28.1% | 50,500 | 0.0% | 0.00% | +33.3% |
Q1 2023 | $1,163,520 | -84.2% | 50,500 | -80.9% | 0.00% | -88.0% |
Q4 2022 | $7,348,959 | -12.9% | 264,256 | -3.9% | 0.02% | -7.4% |
Q3 2022 | $8,436,000 | +4.0% | 274,862 | -0.3% | 0.03% | +3.8% |
Q2 2022 | $8,114,000 | -61.5% | 275,705 | -57.9% | 0.03% | -50.0% |
Q1 2022 | $21,083,000 | -52.6% | 655,348 | -34.2% | 0.05% | -44.7% |
Q4 2021 | $44,435,000 | -21.9% | 996,304 | -11.7% | 0.09% | -27.1% |
Q3 2021 | $56,904,000 | -42.2% | 1,127,919 | -10.1% | 0.13% | -42.7% |
Q2 2021 | $98,460,000 | +42.5% | 1,255,224 | +3.8% | 0.22% | +32.4% |
Q1 2021 | $69,081,000 | -22.4% | 1,209,824 | +13.8% | 0.17% | -22.7% |
Q4 2020 | $89,071,000 | +159.4% | 1,063,406 | +11.0% | 0.22% | +109.5% |
Q3 2020 | $34,333,000 | +49.0% | 958,206 | +0.6% | 0.10% | +26.5% |
Q2 2020 | $23,043,000 | +38.1% | 952,957 | 0.0% | 0.08% | +1.2% |
Q1 2020 | $16,686,000 | +0.5% | 952,957 | 0.0% | 0.08% | +30.2% |
Q4 2019 | $16,601,000 | +10.0% | 952,957 | -3.2% | 0.06% | +1.6% |
Q3 2019 | $15,085,000 | -26.2% | 984,662 | 0.0% | 0.06% | -24.4% |
Q2 2019 | $20,442,000 | -10.6% | 984,662 | 0.0% | 0.08% | -15.5% |
Q1 2019 | $22,864,000 | +12.5% | 984,662 | +0.1% | 0.10% | -5.8% |
Q4 2018 | $20,327,000 | -2.1% | 983,902 | +3.0% | 0.10% | +19.8% |
Q3 2018 | $20,770,000 | +44.1% | 955,402 | +1.1% | 0.09% | +36.5% |
Q2 2018 | $14,418,000 | -19.8% | 945,462 | +3.5% | 0.06% | -24.1% |
Q1 2018 | $17,987,000 | +134.7% | 913,525 | +86.4% | 0.08% | +137.1% |
Q4 2017 | $7,664,000 | – | 490,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |